Skip to main content
. 2024 Feb 6;24(2):100446. doi: 10.1016/j.ijchp.2024.100446

Table 3.

Pre- and post-treatment outcomes for adult samples that received DBT treatment in the selected studies (full-programme).

DBT details n Pre-treatmentM ± SD Pre-treatmentinterval Post-treatmentM ± SD Post-treatmentinterval
Borderline Symptoms List (BSL)
Aggregated RCTs 6–12 months 240 2.25 ± 0.75 [1.50 - 3.00] 1.58 ± 0.98 [0.6 - 2.56]
Aggregated Effectiveness 6–12 months 67 2.11 ± 0.82 [1.28 – 2.93] 1.46 ± 0.93 [0.53 - 2.39]
Difficulties in Emotion Regulation Scale (DERS)
Aggregated RCTs 6–12 months 114 3.62 ± 0.61 [3.01–4.23] 2.42 ± 0.75 [1.67 - 3.17]
Aggregated Effectiveness 6–12 months 233 3.48 ± 0.67 [2.81–4.15] 2.61 ± 0.76 [1.89 - 3.41]
EQ-5D (Utility Scores and VAS)
Aggregated RCTs USc 6–12 months 271 0.65 ± 0.21 [0.44 - 0.86] 0.71 ± 0.20 [0.51 - 0.91]
Aggregated RCTs VAS 6–12 months 271 54.26 ± 33.33 [20.93–87.58] 61.42 ± 20.07 [41.35–81.49]

Note. M = Mean; SD = Standard deviation; DBT = Dialectical Behaviour Therapy; RCT = Randomised Controlled trial; VAS - Visual Analogue Scale.